Granules Pharmaceuticals – Recall of metformin extended-release (ER)
July 6, 2020 - Granules Pharmaceuticals announced a voluntary, consumer-level recall of all lots of metformin ER tablets due to the detection of N-nitrosodimethylamine (NDMA) levels in excess of acceptable FDA levels.
Download PDF
